Allocation of public offering proceeds to laser eyewear manufacturing costs
First written in FY2021-Q3. 2 of 5 entries say "Restated". Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026ReframedAnnual report
「The proceeds from the Company's public offering are scheduled to be applied to working capital for the laser and optical solutions business and for headquarters, including personnel expenses, rent and intellectual property expenses.」
The stated use of the public offering proceeds changed from being centered on laser eyewear manufacturing costs to include working capital for the laser and optical solutions business and headquarters. - FY2024ReframedAnnual report
「Regarding mass production of the laser eyewear business, the Company believes that enhanced functionality is necessary for market acceptance. It will manufacture the products while expanding development services to enhance the functionality of retinal-projection products and expanding the market for eye-health check services.」
The planned use of the ¥2,933.885 million raised through the listing changed from being centered on mass-production costs for laser eyewear to a plan including development costs for enhancing functionality and working capital for the business and headquarters. - FY2022RestatedAnnual report
「The proceeds from the Company's public offering are scheduled to be applied to the manufacturing costs of retinal-scanning laser eyewear.」
The Company has reconfirmed its policy of applying the public offering proceeds to laser eyewear manufacturing costs. - FY2021RestatedAnnual report
「The proceeds from the Company's public offering are scheduled to be applied to the manufacturing costs of retinal-scanning laser eyewear.」
The planned application of the public offering proceeds to laser eyewear manufacturing costs is reiterated. - FY2021-Q3First statedAnnual report
「The proceeds are scheduled to be applied as follows: manufacturing costs for laser eyewear.」
The filing specifies manufacturing costs for laser eyewear as a use of the proceeds raised through the public offering.